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Background
Antibiotic resistance in S. aureus is one of the major
concerns and the rate of MRSA has dramatically
increased in recent years. Clindamycin belongs to the
MLS group and is used to treat skin and soft tissue
infections. Resistance to clindamycin may be inducible
(iMLSB) or constitutive (cMLSB) and it is present both
in MRSA and MSSA. Treatment failure has been
reported both in iMLSB and cMLSB cases. Knowledge
on clindamycin resistance is important for its proper
use. Hence, the present study was done to detect clinda-
mycin resistance among S. aureus causing skin and ear
infections.
Methods
84 samples (skin – 55, ear discharge – 29) were col-
lected from the OPD and wards of tertiary hospital in
Chennai. Isolation and identification of S. aureus was
done according to standard protocol. Antibiotic suscept-
ibility pattern was tested for all isolates to various anti-
biotics. MRSA screening was done by cefoxitin disc
diffusion method. Erythromycin induced clindamycin
resistance was detected by using D-test. MIC was deter-
mined by agar dilution method.
Results
From the 84 clinical samples, 49 S. aureus isolates were
obtained of which 32 (65%) were MRSA. 32 (65%) strains
were resistant to erythromycin and 3 (6.1%) showed resis-
tance to clindamycin with MIC of 256μg/ml. Of the 32
erythromycin resistant S. aureus isolates, 18 exhibited
inducible clindamycin resistance. All clindamycin resistant
isolates were found to be MRSA.
Conclusion
Increasing resistance to clindamycin has been found
among MRSA indicating urgent need for guidelines on
its proper use to decrease the morbidity and mortality
by MRSA infections.
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